David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/a2/52/ca/a252cabc-b674-d843-f979-9c9dd88a3ab9/mza_2965055271400175860.png/600x600bb.jpg

Product Success Podcast: Quality and Medical Devices

Propel

10 episodes

7 months ago

This podcast brings together thought leaders from the health and life science industry talking about compliance, quality and product success in medical devices. Hosts: Chuck Serrin, VP Industry Marketing, Medical Device & Life Sciences Rachel Jang, Partner Enablement Manager of Propel

All content for Product Success Podcast: Quality and Medical Devices is the property of Propel and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Business

Science,

Life Sciences

https://episodes.castos.com/60a3fe00b8d6a1-07389751/images/S1-E4-Dave-Dykeman.png

David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies

Product Success Podcast: Quality and Medical Devices

39 minutes 13 seconds

4 years ago

David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies

Leading Patent Attorney David Dykeman discusses how medtech funding is at an all-time high, so optimizing your company’s patent portfolio is paramount. Patents are the new currency! In addition, intellectual property (IP) are the keys to the castle and must secure and control it across global partnerships, collaboration and change.